Concepedia

Author

Yassamin Feroz Zada

Montreal Heart Institute

Also Known As

Y F Zada, Y Feroz Zada, Y. Zada, Yassamin Feroz Zada

29

Publications

1.2K

Citations

13

H-Index

30

Concepts

All Affiliations

Montreal Heart InstituteUniversité de MontréalHôpital Maisonneuve-RosemontCentre Hospitalier de l’Université de MontréalBrigham and Women's Hospital
YF

About

Yassamin Feroz Zada is an author at Montreal Heart Institute specializing in cardiovascular disease, medicine, and cardiovascular genetics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

2

2

116

2

Public Health

1

1

22

3

Cell Biology

1

1

94

4

Epidemiology

1

1

22

5

Global Health

1

1

22

Yassamin Feroz Zada

×

13

Publications

1.1K

Citations

11

H-Index

YearCitations

DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions

Manuel Buscarlet, Sylvie Provost, Yassamin Feroz Zada,

Blood

2017

371

Pharmacogenomic Determinants of the Cardiovascular Effects of Dalcetrapib

Jean‐Claude Tardif, Éric Rhéaume, Louis‐Philippe Lemieux Perreault,

Circulation Cardiovascular Genetics

2015

183

Lineage restriction analyses in CHIP indicate myeloid bias for TET2 and multipotent stem cell origin for DNMT3A

Manuel Buscarlet, Sylvie Provost, Yassamin Feroz Zada,

Blood

2018

134

Replication of TPMT and ABCC3 Genetic Variants Highly Associated With Cisplatin-Induced Hearing Loss in Children

Kusala Pussegoda, Colin J.D. Ross, Henk Visscher,

Clinical Pharmacology & Therapeutics

2013

128

High-sensitivity C-reactive protein is associated with clonal hematopoiesis of indeterminate potential

Lambert Busque, Maxine Sun, Manuel Buscarlet,

Blood Advances

2020

94

Genotype-Dependent Effects of Dalcetrapib on Cholesterol Efflux and Inflammation

Jean‐Claude Tardif, David Rhainds, Mathieu R. Brodeur,

Circulation Cardiovascular Genetics

2016

66

<i>CKM</i> and <i>LILRB5</i> Are Associated With Serum Levels of Creatine Kinase

Marie‐Pierre Dubé, Rosa Zea Zetler, Amina Barhdadi,

Circulation Cardiovascular Genetics

2014

41

Risk of congenital heart defects is influenced by genetic variation in folate metabolism

Karen E. Christensen, Yassamin Feroz Zada, Charles Rohlicek,

Cardiology in the Young

2012

29

Spironolactone Metabolite Concentrations in Decompensated Heart Failure: Insights from the ATHENA-HF Trial

Simon de Denus, Grégoire Leclair, Marie‐Pierre Dubé,

European Journal of Heart Failure

2020

28

Rationale, design, and preliminary results of the Quebec Warfarin Cohort Study

Sylvie Perreault, Payman Shahabi, Robert Côté,

Clinical Cardiology

2018

22

Page 1